Organogenesis Holdings Inc (ORGO) support and resistance · rev $81.0M
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This page maps Organogenesis Holdings Inc (ORGO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
ORGO currently screens at market cap $301.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ORGO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ORGO quote page for the session range and the stock page for the full model.
Not investment advice.